Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to provide the following corporate...
Source: prnewswire.com